*This report is informational only and not medical advice.* Dario Health provides an integrated hardware-software ecosystem for chronic condition management, specifically diabetes and hypertension. Its core differentiator is a proprietary, pocket-sized all-in-one glucose meter that syncs directly with the app. While historically well-rated, the app is currently facing a stability crisis related to iOS 18 and USB-C hardware compatibility, which is driving negative user sentiment.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
4.8
25k reviews
Nemesis
mySugr - Diabetes Tracker Log
The App DNA
What makes this app unique?
For Individuals managing chronic conditions such as diabetes, hypertension, or weight-related health issues who require integrated, data-driven, and human-supported care.
Key features
Proprietary pocket-sized glucometer and blood pressure monitor that sync directly with the app
Automatically sends emergency text messages with blood glucose levels and GPS location to contacts during a hypoglycemic event
Access to human health coaches via phone or chat for guidance and goal setting
Unified logbook for tracking blood glucose, blood pressure, weight, nutrition, and activity
How much does it cost?
The app utilizes a hardware-enabled subscription model where the digital hub facilitates proprietary medical device sales and recurring coaching revenue.
Velocity
Maintenance developmentperformanceShow more...
The app has not released a major feature update in the observed data, with the most recent release being a minor update on February 6, 2026. Given the lack of release notes and the time elapsed since the last update, the development cadence is classified as maintenance. There is no evidence of active feature development or recent product iteration.
Who built it?
User Sentiment
What do users think recently?
Review voice lately leans frustrated. Users appreciate portability and hardware design and ease of use, but report os and hardware compatibility.
How are ratings & reviews evolving?
What users say, by theme
- Portability and Hardware Design
- Ease of Use
Unlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Dario Health
How's the Medical market?
The rivals identified
By mySugr GmbH
mySugr is the dominant software-led competitor with a massive user base and an aggressive release cadence (14 updates in 6 months) that outpaces Dario's software iteration.
- Gamified 'Diabetes Monster' UX designed to drive daily engagement, contrasting with Dario's clinical, utility-first interface.
- Broad hardware agnostic approach, supporting data imports from various pumps and CGMs, whereas Dario is optimized for its proprietary hardware bundle.
- PDF report generation specifically formatted for physician review, a feature that anchors its position in the clinical workflow.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Dario Health
Where is it heading?
- Upset user base reporting immediate crashes on iOS 18 — critical stability failure.
- Hardware communication errors with USB-C (iPhone 16) — core product functionality blocked.
- v5.10.1 focused on profile navigation rather than fixing reported OS compatibility issues.
The SWOT
- Proprietary all-in-one hardware form factor
- GPS-enabled emergency Hypo Alert system
- Direct-to-consumer hardware ownership model
- High historical user rating and brand trust
- Integration with third-party CGM data streams
- Expansion into B2B/Employer health plans
- Gamification of daily testing routines
- Adding Apple CarPlay integration for safety
Next best moves
Prioritize iOS 18 and USB-C hardware communication fix
+ 2 more prioritized movesFeature gaps
Gamified 'Diabetes Monster' UX (available in mySugr) +3
Bottom line
Dario's hardware moat is being undermined by software instability. While the physical 'all-in-one' device is a significant strength, the current failure to support iOS 18 and USB-C hardware is a critical churn risk that must be resolved before any feature expansion is considered.
Unlock 4 critical frictions, 3 market threats, 2 more prioritized moves and the analyst’s take.
Access the full report for freeReport last updated